This inventor holds 1 USPTO granted patent. Top assignee: Hanmi Science Co., Ltd.. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Jae Hyuk Jung: Innovator in Diabetes Treatment
Introduction
Jae Hyuk Jung is a notable inventor based in Goyang-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of type 2 diabetes mellitus. His innovative approach has led to the development of a novel method for preparing sitagliptin, a key medication for managing this condition.
Latest Patents
Jae Hyuk Jung holds a patent for a method of preparing sitagliptin and the intermediates used in its production. This patent outlines a simple, low-cost method that enhances the efficiency of synthesizing sitagliptin, which acts as a DPP-IV (dipeptidyl peptidase IV) inhibitor. This invention is crucial for improving treatment options for individuals suffering from type 2 diabetes.
Career Highlights
Jae Hyuk Jung is currently employed at Hanmi Science Co., Ltd., where he continues to focus on innovative pharmaceutical solutions. His work has not only contributed to the company's portfolio but has also advanced the field of diabetes treatment.
Collaborations
Some of his coworkers include Nam Du Kim and Ji Yeon Chang, who collaborate with him on various projects within the company. Their teamwork fosters an environment of innovation and progress in pharmaceutical research.
Conclusion
Jae Hyuk Jung's contributions to the field of diabetes treatment through his patent for sitagliptin preparation exemplify the impact of innovative thinking in healthcare. His work at Hanmi Science Co., Ltd. continues to pave the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile